Role of Carboxy Terminal Propeptide of Type I and Type III Procollagen (PICP and PIIICP) Toward the Severity Degree of Mitral Valve Regurgitation in Children’s Rheumatic Heart Disease

Renny  Suwarniaty; Mohammad Saifur Rohman; Tinny Endang Hernowati; Wisnu Barlianto

doi:10.3889/oamjms.2020.4798

Authors

Renny Suwarniaty Doctoral Program of Medical Science, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia; Department of Pediatrics, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
Mohammad Saifur Rohman Department of Cardiology and Vascular Medicine, Dr. Saiful Anwar General Hospital, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
Tinny Endang Hernowati Department of Clinical Pathology Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
Wisnu Barlianto Department of Pediatrics, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2020.4798

Keywords:

Heart, Procollagen, PICP, PIIICP, Rheumatic

Abstract

BACKGROUND: Rheumatic heart disease (RHD) is recognized as a heart disease that occurs as a result of sequelae in acute rheumatic fever (ARF), characterized by the occurrence of defects in the heart valves. The most common manifestation of childhood RHD is mitral regurgitation (MR). The role of inflammation and oxidative stress in RHD also involves several components consisting of carboxy-terminal pro-peptide of Type I procollagen (PICP) and carboxy-terminal pro-peptide of Type III procollagen (PIIICP).

AIM: The aim of this study was to know whether PICP and PIIICP can be used to measure the severity level of mitral valve regurgitation.

METHODS: This research is considered as descriptive-analytic research, and using cross-sectional analysis. Forty RHD patients underwent echocardiographic examinations to measure Wilkin and effective regurgitant orifice area scores. Patients were classified into ARF without valve abnormalities, mild, moderate, and severe MR. PICP and PIIICP were with ARF through venous blood and ELISA was examined. Data were analyzed by employing SPSS 22 with p = 0.05). Wilkins scores and PICP levels have a regression coefficient of 0.296 with a p-value of 0.032.

RESULTS: There was a significant difference in PICP level among the studied sample groups with a p = 0.012, (p < 0.05), with insignificant difference in PIIICP level among sample groups with a p = 0.083, greater than α = 0.05 (p > 0.05). Wilkins scores and PICP level have a regression coefficient of 0.296 with a p = 0.032 (p < 0.05), while PIIICP level has a regression coefficient of 0.093 with a p = 0.568 (p > 0.05).

CONCLUSION: There is no significant increase indicated on PIIICP level, but PICP level indicates a significant increase in RHD group with severe mitral valve abnormalities. PICP can be used to measure the severity level of mitral valve regurgitation.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

World Health Organization. Rheumatic Fever and Rheumatic Heart Disease, Report of a WHO Study Group. Geneva: World Health Organization, Technical Report Series, No.923; 2011.

World Health Organization. The Global Burden of Disease, Report of a WHO Study Group. Geneva: World Health Organization, Technical Report Series, No.815; 2014.

Carapetis JR, Beaton A, Cunningham MW, Guilherme L, Karthikeyan G, Mayosi BM, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers. 2016;2:1504. PMid:27188830

Goldstein I, Rebeyrotte P, Parlebas J, Halpern B. Isolation from heart valves of glycopeptides which share immunological properties with Streptococcus haemolyticus group a polysaccharides. Nature. 2008;219:866-8. https://doi. org/10.1038/219866a0

Delunardo F, Scalzi V, Capozzi A, Camerini S, Misasi R, Pierdominici M, et al. Stresptococcal-vimentin cross reactive antibodies induce microvascular cardiac endhothelial proinflammatory phenotype in rheumatic heart disease. Clin Exp Immunol. 2013;173(3):419-29. https://doi.org/10.1111/ cei.12135 PMid:23663103

Toor D, Vohra H. Immune responsiveness during disease progression from acute rheumatic fever to chronic rheumatic heart disease. Microbes Infect. 2012;14(12):1111-7. https://doi. org/10.1016/j.micinf.2012.07.003

Lopez B, Gonzales A, Diez J. Circulating biomarkers of collagen metabolism in cardiac diseases. Circulation. 2010;121(14):1645-54. PMid:20385961

Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69(3):562- 73. https://doi.org/10.1016/j.cardiores.2005.12.002 PMid:16405877

Martos R, Baugh J, Ledwidge M, O’Loughlin C, Conlon C, Patle A, et al. Diastolic heart failure: Evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation. 2007;115(7):888-95. https://doi.org/10.1161/ circulationaha.106.638569 PMid:17283265

Banerjee T, Mukherjee S, Ghosh S. Clinical significance of markers of collagen metabolism in rheumatic mitral valve disease. PLoS One. 2014;9(3):e90527. https://doi.org/10.1371/ journal.pone.0090527 PMid:24603967

Vijayalakshmi IB, Vishnuprabvu RO, Chitra N, Rajasri R, Anuradha TV. The efficacy of echocardiographic criterions for the diagnosis of carditis in acute rheumatic fever. Cardiol Young. 2008;18(6):586-92. https://doi.org/10.1017/ s1047951108003107 PMid:18845020

Dahlan MS. Besar Sampel Dan Cara Pengambilan Sampel Dalam Penelitian Kedokteran Dan Kesehatan. Jakarta: Salemba Medika; 2010.

Beniwal R, Bhaya M, Panwar RB, Panwar S, Singh A. Diagnostic criteria in rheumatic heart disease. Global Heart. 2015;10(1):81- 2. https://doi.org/10.1016/j.gheart.2014.07.001 PMid:25754572

Guilherme L, Kalil J. Rheumatic fever and rheumatic heart disease: Cellular mechanisms leading autoimmune reactivity and disease. J Clin Immunol. 2010;30(1):17-23. https://doi. org/10.1007/s10875-009-9332-6 PMid:19802690

Lancellotti P, Moura L, Pierard LA, Badano L, Zamorano JL. European association of echocardiography recommendations for the assessment of valvular regurgitation. Part 1: Aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr. 2010;11(3):307-32. https://doi.org/10.1093/ ejechocard/jeq031 PMid:20375260

Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: An analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J. 1988;60(4):299-308. https://doi.org/10.1136/hrt.60.4.299 PMid:3190958

Lijnen PJ, Maharani T, Finahari N, Prihadi JS. Serum collagen markers and heart failure. Cardiovasc Haematol Disord Drug Targets. 2012;12(1):51-5. https://doi. org/10.2174/187152912801823147 PMid:22524171

Jensen LT, Host NB. Collagen: Scaffold for repair or execution. Cardiovasc Res. 2007;33(3):535-9. PMid:9093523

Aloui S, Zidi W, Ouali S, Guizani I, Hadj-Taieb S, Mourali MS, et al. Association of matrix metalloproteinase 3 and endogenous inhibitors with inflammatory markers in mitral valve disease and calcification. Mol Biol Rep. 2018;45(6):2135-43. PMid:30302620

Seo WY, Kim JH, Baek DS, Kim SJ, Kang S, Yang WS, et al. Production of recombinant human procollagen Type I C-terminal propeptide and establishment of a sandwich ELISA for quantification. Sci Rep. 2017;7:15946.

Mahfouz RA, Eldawei K, Elawady W, Dewedar A. Biomarkers score for patients with mitral stenosis: A useful conjunction with Wilkins’s score for early intervention. Heart Res Open J. 2015;2(4):118-25. https://doi.org/10.17140/hroj-2-121